Jorge Bermudez
Direttore/Membro del Consiglio presso Drugs for Neglected Diseases initiative
Profilo
Jorge Bermudez is currently the Director at Drugs for Neglected Diseases initiative and Vice President-Health Production & Innovation at Fundação Oswaldo Cruz.
He was previously the Executive Director at Unitaid from 2007 to 2011.
He received his undergraduate degree from Federal University of Rio de Janeiro in 1971 and his graduate degree from the same university in 1976.
Posizioni attive di Jorge Bermudez
| Società | Posizione | Inizio |
|---|---|---|
Drugs for Neglected Diseases initiative
 Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Direttore/Membro del Consiglio | - |
| Fundação Oswaldo Cruz | Corporate Officer/Principal | 01/01/2011 |
Precedenti posizioni note di Jorge Bermudez
| Società | Posizione | Fine |
|---|---|---|
Unitaid
 Unitaid Miscellaneous Commercial ServicesCommercial Services Unitaid operates organization that invests in innovations to prevent, diagnose and treat HIV/AIDS. The company was founded in 2006 and is headquartered in Geneva, Switzerland. | Corporate Officer/Principal | 01/01/2011 |
Formazione di Jorge Bermudez
| Federal University of Rio de Janeiro | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Health Technology |
Unitaid
Unitaid Miscellaneous Commercial ServicesCommercial Services Unitaid operates organization that invests in innovations to prevent, diagnose and treat HIV/AIDS. The company was founded in 2006 and is headquartered in Geneva, Switzerland. | Commercial Services |
- Borsa valori
- Insiders
- Jorge Bermudez
